- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: TKI
Total 500 results
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Peking University People's HospitalCompletedSoft Tissue Sarcoma | Bone Sarcoma | Refractory TumorChina
-
The Fourth Affiliated Hospital of Zhejiang University...CompletedNSCLC | EGFR Gene Mutation | Non-small-lung-cell CancerChina
-
Fundacion CRIS de Investigación para Vencer el...Apices Soluciones S.L.; Incyte Biosciences UKActive, not recruitingChronic Myeloid Leukemia, Chronic PhaseSpain
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.Active, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Institute of Cancer Research, United KingdomActive, not recruitingNSCLCUnited Kingdom, France, Switzerland, Italy, Spain
-
Bridge Biotherapeutics, Inc.TerminatedNSCLCKorea, Republic of
-
Fudan UniversityCompleted
-
European LeukemiaNetLudwig-Maximilians - University of Munich; Heidelberg UniversityActive, not recruitingChronic Myeloid LeukemiaGermany, Netherlands
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Ocular Therapeutix, Inc.Active, not recruitingNon-proliferative Diabetic RetinopathyUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNon-Squamous Non-Small Cell Lung CancerChina
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated MelanomaUnited States
-
BayerCompletedCoronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection | Malignant Solid TumorsUnited States
-
Otsuka Beijing Research InstituteActive, not recruitingAcute Lymphoblastic Leukemia | Chronic Myeloid LeukemiaChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
PfizerCompleted
-
Novartis PharmaceuticalsActive, not recruiting
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCChina
-
Imperial College LondonUniversity of Sheffield; Medical Research Council; University of Cambridge; National...Active, not recruitingPulmonary Arterial HypertensionUnited Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedNon-Small-Cell Lung CarcinomaUnited States, China, Taiwan, Spain, Korea, Republic of, France, Canada, Hong Kong, Japan, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Beta Pharma ShanghaiActive, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Yuhan CorporationCompleted
-
Poitiers University HospitalActive, not recruiting
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Laibin People's HospitalCompletedThe Primary Study Metric is Progression-free Survival (PFS)
-
Masaryk UniversityActive, not recruitingChronic Myeloid Leukemia, Chronic Phase | Withdrawal;DrugCzechia
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Basilea PharmaceuticaArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedSolid TumorUnited States, Italy
-
Massachusetts General HospitalNovartisActive, not recruitingLung CancerUnited States
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
M.D. Anderson Cancer CenterExelixisWithdrawnHepatocellular Carcinoma | Liver CancerUnited States
-
University of JenaCompletedChronic Myeloid LeukemiaGermany, Switzerland, Czechia
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedRenal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States, Argentina, Brazil, Australia, Singapore, New Zealand, Russian Federation, Mexico, Peru, Chile
-
PfizerCompletedRenal Cell Carcinoma (RCC)United States
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia, Chronic PhaseChina
-
Oslo University HospitalAstraZenecaActive, not recruitingLung Cancer | Targeted TherapySweden, Finland, Denmark, Lithuania, Norway
-
Calithera Biosciences, IncCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, United Kingdom, Australia, France, Italy, Germany, Spain, New Zealand
-
Medical College of WisconsinMemorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute; University... and other collaboratorsCompletedLeukemia, Myeloid, ChronicUnited States
-
Northwestern UniversityCompletedCancer | Communication | Medication Adherence | Cancer, Treatment-Related | Tyrosine Kinase InhibitorUnited States
-
xunaNanfang Hospital of Southern Medical University; Sun Yat-Sen Memorial Hospital... and other collaboratorsWithdrawnProphylactic HQP1351 Therapy | Third Generation TKIChina
-
Intergroupe Francophone de Cancerologie ThoraciqueNovartisCompletedNon Small Cell Lung Cancer | MET Alterations | METex14 MutationsFrance
-
Novartis PharmaceuticalsCompleted
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdSunshine Lake Pharma Co., Ltd.Terminated